Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
~$BIEL-FDA "L2 Looking Betterrr" for an UPTREND Here
$$$$$$ Let's get some BIG Long Awaited News (WALGREEN, etc)
~$BIEL-Ready for a Trend-Reversal?? L2-Looking Muchhh Betterrrr
~$BIEL- PR NEWSWIRE OUT...Just Released
~Damn $BIEL-FDA..Trading like CHIT..CATCH Da Bottom...-n-Wait for Some BIGGG-NEWS(Walgreens, Etc, Etc).
$$$$$$$$$$$$$$$$$$$$$$$$$
~PR NEWSWIRE OUT
~Definitely a Buy & Wait..Slow Nibbles & Bites for Quite Some Time Here....
~Damnn..What happened here? Loading Zone??
~$60-Billion Order Next Week? Weeeeeeeeeee
~$BIEL & *McKesson-$190B*Revs!-$MCK(NYSE)*4,000+HealthMart-Locations*
$BIEL Making some BIGGGG Friends
https://en.m.wikipedia.org/wiki/Health_Mart
$MCK(NYSE)
https://en.m.wikipedia.org/wiki/McKesson_Corporation
www.Mckesson.com/pharmacies/independent-retail/pharmacy-brands/health-mart/
http://HealthMart.com
http://HealthMart.com/faqs
~$BIEL "UPTREND CONTINUES"..MM's Getting READYYYY....
~$190 BILLION-REVS*McKesson$MCK(NYSE)*?
Linked Up with $BIEL for their FDA Recently Approved ActiPatch?
Let's get that Mega PR! $$$$$$$$$$$$$$$$
https://en.m.wikipedia.org/wiki/Health_Mart
***4,000+ Retail Stores***
https://en.m.wikipedia.org/wiki/McKesson_Corporation
***B-B-BILLIONS***
www.Mckesson.com/pharmacies/independent-retail/pharmacy-brands/health-mart/
http://HealthMart.com
http://HealthMart.com/faqs
~$BIEL-"NEXT WAVE UPPP"...*BIGGG NEWS SOON*???
~$BIEL-Getting Ready for an UPTREND..NEWS Coming???
Why Not?
~"We're Talking with Them"- Nice! Orders are Placed Well in Advance for Future Quarters in Big Retail...
Let's get that "Order Placed" News!
**Walgreen's, Costco Walmart, CVS, etc**
Just One..Set's it OFF
~Called-CEO..Said Everything will be in the Audit..NASDAQQQ $$$$$$$ $ICBU
~WALGREENS-US "Purchase Orders" for Next-Quarter Retail Planograms, is What I Expect Next....
Only a Matter of Timeeee
"NASDAQ Uplist" with Audited Financials Soon?
~Hmmmmm..We could have a Serious Runnerrr here
~I think they Play it Smarttt Here.. Well See! FDA WALGREENS, WALMART, ETC.. Too Much Going on with $BIEL
~NICE VOL-"HUGE NEWSSS"!..EOD BREAKOUT, If Not..Earlier $ICBU
~Hmmm.."LOADING ZONE" B4 NEWS COME$$
~HUGE: "KRSNA MINERALS currently has Contracts with the Chinese Government to supply Manganese and Iron Ore to China".
"The recoverable Asset Values are in excess of ***$700 Million Dollars*** for the total claims Owned by KRSNA MINERALS".
$$$$$$$$$$$$$$$$$$$ $ICBU
~$60Million Order?? WOW! "01+" Copper Bound
Why has this one been tanking lately?
~This Should be 100%+ Today By Now...
~NEWS OUT
~Great Call! Congrat$$$$$$
~"Assigned in collaboration with Valeant BDM to Exclusively Commercialize Actipatch® (www.Actipatch.com) in MENA region in 2017"
That's a Tidbit for youu...
"Bioelectronics Corp" & $10 BILLION Rev Monster
"Valeant Pharmaceuticals" (NYSE: $VRX)
$$$$$$$$$$$$$$$$$$$$$$$
http://Valeant.com
~$BIEL-Associated w/"$10B VALEANT Pharmaceutical($VRX)???
http://Valeant.com
$10 Billion Revenues - (NYSE)$VRX
Hmmmm.."Many Products & Subsidiaries" :
https://en.m.wikipedia.org/wiki/Valeant_Pharmaceuticals
"Valeant Pharmaceuticals International, Inc."
Public Company: NYSE: VRX TSX: VRX
S&P/TSX 60 component
Pharmaceutical industry Founded 1960
Headquarters Laval, Quebec, Canada
Key people:
Joseph C. Papa (Chairman and CEO), Paul Herendeen (CFO), Milan Panic (Founder)
***Products***
Xifaxan, Uceris, Arestin, Jublia, Solodyn, Ziana, Acanya, Atralin, Retin-A Micro, Microsphere, Onexton, Elidel, Glumetza, Wellbutrin XL, Isuprel, Xenazine, Nitropress,
Cuprimine, Targretin, Zovirax, Syprine
Revenue US: $9.674 billion (2016)
Operating income US: $0.566 billion (2016)
Net Income US: $2.409 billion (2016)
Total Assets US: $43.529 billion (2016)
Total Equity US: $3.152 billion (2016)
Number of employees: 21,500 (2016)
***Subsidiaries***
Bausch & Lomb
Salix Pharmaceuticals
Medicis Pharmaceutical
Solta Medical
Dendreon
OraPharma
Obagi
Website: Valeant.com
~PR-Machine Rolling.."FDA-Approval" Opening Doorsss.. GLOBALLY
~NEWS OUT on $BIEL
~Correct! *WALMART & Bioelectronics/BIEL* -HUGE CONNECTION:
"Next PR" for ORDERS PLACED based on Future Quarter Retail Planograms, is Expected Soon:
It's Not Only "USA WALGREEN'S & COSTCO's Retail Store Shelves" that ActiPatch is Expected In Soon.
*You can Almost BANK on "WAL-MART" , In Addition:
https://www.linkedin.com/in/hudsonlevy
http://www.marketwired.com/press-release/bioelectronics-welcomes-new-additions-to-marketing-team-1280482.htm
~Back to "15-20's NEXT WEEEK"-$BIEL *FDA-APPROVAL* is "No Temp Fluff News" $$$$$$
"REAL DEAL HERE"..Bring on the MEGA NEWS Next
~$BIEL-Associated w/ "$10B VALEANT($VRX)??? www.Valeant.com
$10 Billion Revenues - (NYSE)$VRX
Hmmmm.."Many Products & *Subsidiaries*" :
https://en.m.wikipedia.org/wiki/Valeant_Pharmaceuticals
"Valeant Pharmaceuticals International, Inc."
Public company NYSE: VRX TSX: VRX
S&P/TSX 60 component
Pharmaceutical industry Founded 1960
Headquarters Laval, Quebec, Canada
Key people
Joseph C. Papa (Chairman and CEO), Paul Herendeen (CFO), Milan Panic (Founder)
***Products***
Xifaxan
Uceris
Arestin
Jublia
Solodyn
Ziana
Acanya
Atralin
Retin-A Micro
Microsphere
Onexton
Elidel
Glumetza
Wellbutrin XL
Isuprel
Xenazine
Nitropress
Cuprimine
Targretin
Zovirax
Syprine
Revenue Decrease US$9.674 billion (2016)
Operating income
Decrease -US$0.566 billion (2016)
Net income
Decrease -US$2.409 billion (2016)
Total assets Decrease US$43.529 billion (2016)
Total equity Decrease US$3.152 billion (2016)
Number of employees
21,500 (2016)
***Subsidiaries***
Bausch & Lomb
Salix Pharmaceuticals
Medicis Pharmaceutical
Solta Medical
Dendreon
OraPharma
Obagi
Website: Valeant.com
~NEWS: "SHORT SQUEEZE ALERT–Top 10 Most ShortedStocks–VPOR,USMJ*BIEL*UNGS–Buy-In Set To Catapult PPS"
Source: InvestorsHub NewsWire
Dallas, TX – March 3, 2017 – Wall Street Corner Report:
"Companies that have Large Volumes of Trading will often attract short sellers trying to hedge against an upward PPS trend. However, when that shorting volume puts a company in the top ten most actively shorted stocks (See OTCShortReport.com), that is a good indication that the short selling volume has exceeded the hedge opportunity and crossed into short squeeze risk. We believe these 4 companies are poised to benefit from a short squeeze buy-in that catapults PPS as short sellers are forced to buy stock and cover their short positions.
-Vapor Group, Inc (USOTC: VPOR)
-North American Cannabis Holdings (USOTC: USMJ)
-Bioelctronics Corp (USOTC: BIEL)
-Sylios Corp (USOTC: UNGS)
"Wall Street Corner Report is the premier discovery site for promising, yet undiscovered small and micro-cap stocks featuring opportunities in an ethical, professional, and responsible manner. We're not fiendishly 'short' sighted nor are we here to dream the impossibly 'long' dream. We take a practical view on the big ideas of well-intentioned management and look to profit on each reasonably achievable step the well intentioned mangers take toward their big ideas."
www.wallstreetcornerreport.com/more-news/
https://twitter.com/WallStCornerRpt
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
Jack Taylor
info@wallstreetcornerreport.com
~YUP-WALGREEN'S US: 8,000+Stores: *ORDER PRs* are NEXT: Big Chains "ORDER" Based on "Retail Planograms" (Walmart,CVS,Walgreens,etc)
When ActiPatch is on the Shelves themselves, is actually Irrelevant, Short Term..
***It's Orders Placed EARLY for the Next Period/Quarter*** We should hear about Very Soon $$$$$$$$$$$$$$$
https://www.thebalance.com/planogram-pog-definition-and-example-2892232
~EXACTLY-Next PR likely Big Chain Orders(Walgreen's, Costco, Walmart,CVS) for Shelves in Aug/Sept/Oct...
~HUGE-"*WALMART & Bioelectronics/BIEL*" BIG CONNECTION:
Not Just "USA WALGREEN'S & COSTCO's Retail Store Shelves" that ActiPatch is Expected In Very Soon.
*You can Almost BANK on "WAL-MART" , In Addition:
https://www.linkedin.com/in/hudsonlevy
http://www.marketwired.com/press-release/bioelectronics-welcomes-new-additions-to-marketing-team-1280482.htm